MeSH term
Frequency | Condition_Probility | Adolescent | 15 | 0.0 |
Adult | 22 | 0.0 |
Aged | 10 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Cardiomyopathy, Hypertrophic/*genetics | 7 | 36.0 |
Child | 10 | 0.0 |
Child, Preschool | 7 | 0.0 |
DNA Mutational Analysis | 6 | 0.0 |
Exons/genetics | 2 | 0.0 |
Female | 23 | 0.0 |
Humans | 38 | 0.0 |
Infant | 2 | 0.0 |
Male | 23 | 0.0 |
Middle Aged | 16 | 0.0 |
Mutation | 7 | 0.0 |
Myosin Heavy Chains/*genetics | 9 | 22.0 |
Research Support, Non-U.S. Gov't | 32 | 0.0 |
Ventricular Myosins/*genetics | 7 | 77.0 |
Echocardiography | 2 | 0.0 |
Electrocardiography | 2 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Haplotypes | 6 | 0.0 |
*Mutation | 9 | 0.0 |
Pedigree | 15 | 0.0 |
Animals | 5 | 0.0 |
Cardiomyopathy, Hypertrophic/genetics | 2 | 22.0 |
Chromosomes, Human, Pair 14/*genetics | 2 | 2.0 |
Comparative Study | 5 | 0.0 |
Mutation/*genetics | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Base Sequence | 7 | 0.0 |
DNA Primers | 2 | 0.0 |
Family Health | 3 | 0.0 |
Genetic Markers | 6 | 0.0 |
Genotype | 6 | 0.0 |
Homozygote | 2 | 0.0 |
Phenotype | 10 | 0.0 |
Polymorphism, Single-Stranded Conformational | 4 | 0.0 |
English Abstract | 2 | 0.0 |
Myosin Heavy Chains/genetics | 4 | 18.0 |
Sarcomeres/*genetics | 2 | 66.0 |
Tropomyosin/genetics | 2 | 28.0 |
Troponin I/genetics | 2 | 50.0 |
Troponin T/genetics | 2 | 28.0 |
Chromosome Mapping | 8 | 0.0 |
*Chromosomes, Human, Pair 14 | 6 | 3.0 |
Cardiomyopathy, Hypertrophic/*genetics/pathology | 2 | 40.0 |
Carrier Proteins/*genetics | 5 | 0.0 |
*Heterozygote | 3 | 0.0 |
Myosins/*genetics | 5 | 9.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
Exons | 3 | 0.0 |
*Mutation, Missense | 2 | 0.0 |
Amino Acid Metabolism, Inborn Errors/*genetics | 2 | 5.0 |
Linkage (Genetics) | 3 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Muscle, Skeletal/pathology | 2 | 3.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Models, Molecular | 3 | 0.0 |
*Point Mutation | 2 | 0.0 |
Cardiomyopathy, Hypertrophic/epidemiology/*genetics | 2 | 100.0 |
Muscle Proteins/*genetics | 2 | 1.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Introns | 2 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Genetic Markers/genetics | 2 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
DNA Mutational Analysis/*methods | 3 | 2.0 |
Genetic Screening/*methods | 2 | 1.0 |
Sequence Alignment | 2 | 0.0 |
Cohort Studies | 2 | 0.0 |
*Genetic Screening | 2 | 1.0 |
Troponin T/*genetics | 2 | 18.0 |
Prevalence | 2 | 0.0 |
Carrier Proteins/genetics | 2 | 0.0 |
